|  | ARID1a expression |  | BRG1 expression |  | BRM expression | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Negative | Positive | p-value |  |  | Negative | Positive | p-value |  |  | Negative | Positive | p-value | ||||||||
Total | 147* | Â | 14 | 9.5% | 133 | 90.5% | Â | 149* | Â | 7 | 4.7% | 142 | 95.3% | Â | 148* | Â | 17 | 11.5% | 131 | 88.5% | Â |
Sex | |||||||||||||||||||||
 Female | 13 | 8.8% | 1 | 7.7% | 12 | 92.3% | 1.000 | 14 | 9.4% | 0 | 0.0% | 14 | 100.0% | 1.000 | 14 | 9.5% | 2 | 14.3% | 12 | 85.7% | 0.664 |
 Male | 134 | 13.2% | 13 | 9.7% | 121 | 90.3% | 135 | 90.6% | 7 | 5.2% | 128 | 94.8% | 134 | 90.5% | 15 | 11.2% | 119 | 88.8% | |||
Age group | |||||||||||||||||||||
 <65 | 63 | 46.3% | 5 | 7.9% | 58 | 92.1% | 0.771 | 65 | 47.1% | 2 | 3.1% | 63 | 96.9% | 0.447 | 65 | 47.4% | 7 | 10.8% | 58 | 89.2% | 0.796 |
 >65 | 73 | 53.7% | 8 | 11.0% | 65 | 89.0% | 73 | 52.9% | 5 | 6.8% | 68 | 93.2% | 72 | 52.6% | 9 | 12.5% | 63 | 87.5% | |||
pT stage | |||||||||||||||||||||
 1 | 21 | 14.4% | 2 | 9.5% | 19 | 90.5% | 0.583 | 21 | 14.2% | 1 | 4.8% | 20 | 95.2% | 0.107 | 21 | 14.3% | 3 | 14.3% | 18 | 85.7% | 0.496 |
 2 | 13 | 8.9% | 0 | 0.0% | 13 | 100.0% | 13 | 8.8% | 0 | 0.0% | 13 | 100.0% | 13 | 8.8% | 0 | 0.0% | 13 | 100.0% | |||
 3 | 109 | 74.7% | 12 | 11.0% | 97 | 89.0% | 111 | 75.0% | 5 | 4.5% | 106 | 95.5% | 110 | 74.8% | 14 | 12.7% | 96 | 87.3% | |||
 4 | 3 | 2.1% | 0 | 0.0% | 3 | 100% | 3 | 2.0% | 1 | 0.0% | 2 | 100% | 3 | 2.0% | 0 | 0.0% | 3 | 100.0% | |||
Lymph node metastasis | |||||||||||||||||||||
 pN0 | 54 | 37.0% | 6 | 11.1% | 48 | 88.9% | 0.656 | 54 | 36.5% | 3 | 5.6% | 51 | 94.4% | 0.832 | 54 | 36.7% | 5 | 9.3% | 49 | 90.7% | 0.574 |
 pN 1 | 71 | 48.6% | 5 | 7.0% | 66 | 93.0% | 71 | 48.0% | 3 | 4.2% | 68 | 95.8% | 70 | 47.6% | 8 | 11.4% | 62 | 88.6% | |||
 pN 2 | 10 | 6.8% | 1 | 10.0% | 9 | 90.0% | 10 | 6.8% | 0 | 0.0% | 10 | 100.0% | 10 | 6.8% | 1 | 10.0% | 9 | 90.0% | |||
 pN 3 | 11 | 7.5% | 2 | 18.2% | 9 | 81.8% | 13 | 8.8% | 1 | 7.7% | 12 | 92.3% | 13 | 8.8% | 3 | 23.1% | 10 | 76.9% | |||
Grading | |||||||||||||||||||||
 G1 | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0.095 | 1 | 0.8% | 0 | 0.0% | 1 | 100.0% | 0.901 | 1 | 0.8% | 0 | 0.0% | 1 | 100.0% | 0.123 |
 G2 | 84 | 68.9% | 5 | 6.0% | 79 | 94.0% | 84 | 67.7% | 3 | 3.6% | 81 | 96.4% | 83 | 67.5% | 8 | 9.6% | 75 | 90.4% | |||
 G3 | 38 | 31.1% | 6 | 15.8% | 32 | 84.2% | 39 | 31.5% | 2 | 5.1% | 37 | 94.4% | 39 | 31.7% | 9 | 23.1% | 30 | 76.9% |